Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2025)

Marimed (MRMD) has disclosed Income from Non-Controlling Interests for 10 consecutive years, with -$10000.0 as the latest value for Q4 2025.

  • Quarterly Income from Non-Controlling Interests fell 433.33% to -$10000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Dec 2025, down 24.32% year-over-year, with the annual reading at $28000.0 for FY2025, 24.32% down from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was -$10000.0 at Marimed, down from $7000.0 in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $110000.0 in Q4 2021, with the low at -$19000.0 in Q1 2023.
  • Average Income from Non-Controlling Interests over 5 years is $31700.0, with a median of $16000.0 recorded in 2022.
  • The sharpest move saw Income from Non-Controlling Interests skyrocketed 650.0% in 2023, then plummeted 433.33% in 2025.
  • Over 5 years, Income from Non-Controlling Interests stood at $110000.0 in 2021, then crashed by 96.36% to $4000.0 in 2022, then surged by 650.0% to $30000.0 in 2023, then crashed by 90.0% to $3000.0 in 2024, then tumbled by 433.33% to -$10000.0 in 2025.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at -$10000.0, $7000.0, and -$1000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.